Verrica Pharmaceuticals Inc (VRCA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
75,071,000
EV to revenue ratio (TTM)
2.336
EV to ebitda
-11.7
Financial Performance
Revenue (TTM)
30,321,000
Gross profit (TTM)
11,425,000
EBITDA
-25,964,000
Profitability
Operating margin (TTM)
-194.50%
Profit margin
-102.80%
Return on assets (TTM)
-44.00%
Return on equity (TTM)
-240.40%
Per Share Metrics
Revenue per share (TTM)
1.83
EPS
-1.74
Diluted EPS (TTM)
-1.74
Book value
0.25
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
2.476
Price to book ratio (TTM)
18.63
Growth
Quarterly earnings growth (YoY)
-53.90%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
5
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.495